$25.16
-0.06 (-0.24%)
Open$25.24
Previous Close$25.22
Day High$25.28
Day Low$25.00
52W High$25.49
52W Low$8.20
Volume—
Avg Volume1.11M
Market Cap2.65B
P/E Ratio—
EPS$-3.45
SectorBiotechnology
Analyst Ratings
Strong Buy
22 analysts
Price Target
+187.3% upside
Current
$25.16
$25.16
Target
$72.29
$72.29
$45.76
$72.29 avg
$82.91
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 102.04M | 78.77M | 234.23M |
| Net Income | -321,336,445 | -223,253,667 | -24,379,697 |
| Profit Margin | -314.9% | -299.2% | -10.4% |
| EBITDA | -336,490,248 | -246,769,905 | -31,389,191 |
| Free Cash Flow | — | — | -25,443,977 |
| Rev Growth | +29.5% | +29.5% | +16.3% |
| Debt/Equity | — | — | 0.64 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |